Display options
Cite
Lunyera, J., Mohottige, D., Alexopoulos, A. S., Campbell, H., Cameron, C. B., Sagalla, N., ... & Goldstein, K. M. (2020). Risk for nephrogenic systemic fibrosis after exposure to newer gadolinium agents: A systematic review. Annals of internal medicine, 173(2), 110-119.
Lunyera, Joseph, et al. "Risk for nephrogenic systemic fibrosis after exposure to newer gadolinium agents: A systematic review." Annals of internal medicine 173.2 (2020): 110-119.
Copy Download .nbib Format: MLA
Share it on
Full text links
View full text

J Lunyera, D Mohottige, AS Alexopoulos… - Annals of internal …, 2020 - acpjournals.org

Risk for nephrogenic systemic fibrosis after exposure to newer gadolinium agents: A systematic review.

community settings

Lunyera, Mohottige

GSID: nrn_B6zYBXAJ

Excerpt

Background: The risk for nephrogenic systemic fibrosis (NSF) after exposure to newer versus older gadolinium-based contrast agents (GBCAs) remains unclear. Purpose: To …

Cited by